Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous SVF for Diminished Ovarian Reserve
NCT07901218Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Nov 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous adipose stromal vascular fraction in Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Cumulative clinical pregnancy rate at 6 months. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT07901218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07901218.